Application of Hallmarks of Cancer Gene Signatures Reveals Novel Energetics-Associated Subtypes with Distinct Survival Outcomes in AML von Strain, Paul, Scanlon, Enya, Jellema, Gera, Kennedy, Richard, Mills, Ken I, Blayney, Jaine

Volltext

3197 – RE-PURPOSING OF GENE SIGNATURES IN AML UNCOVERS NOVEL MOLECULAR SUBTYPES ASSOCIATED WITH ENERGETICS von Strain, Paul, Scanlon, Enya, Jellema, Gera, Kennedy, Richard, Blayney, Jaine, Mills, Ken

Volltext

Stability of rare TP53 co-mutations in AML patients von Bloom, Kenneth Joel, Idica, Adam, Smart, Dave, Allen, Wendy, Scanlon, Enya, Clark, Jordan

Volltext

Defining an IBD-like subgroup in consensus molecular subgroups of colorectal cancer and transcriptomic biomarker development for at-risk patients von Scanlon, Enya, Murphy, Seamus J, Kennedy, Richard D., Blayney, Jaine K.

Volltext

Abstract 2999: Identification of Src's role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approac... von McCabe, Niamh Helen, Stevenson, Leanne, Scanlon, Enya, Keminer, Oliver, Kennedy, Richard D., Windshuegel, Bjoern, Blayney, Jaine K., Turkington, Richard C.

Volltext

Drugging the undruggable: A market readiness analysis for KRAS-G12C von Loupakis, Fotios, Bloom, Kenneth Joel, Allen, Wendy, Scanlon, Enya, Stacey, Isabel, Keeling, Derry Mae, Patel, Nital, Clark, Jordan

Volltext

Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches von McCabe, Niamh H., Stevenson, Leanne, Scanlon, Enya, Douglas, Rosalie, Kennedy, Susanna, Keminer, Oliver, Windshügel, Björn, Zisterer, Daniela, Kennedy, Richard D., Blayney, Jaine K., Turkington, Richard C.

Volltext